Dementia is a persistent, progressive state of cognitive decline against which pharmacological intervention has a modest efficacy, reducing behavioral but not cognitive symptoms. Therefore, different non-pharmacological therapies have been developed; the most scientifically recognized are cognitive therapies that have improved cognitive function and daily life activities.
Objective:
To evaluate the effectiveness of a multicomponent cognitive stimulation therapy (SADEM) on cognitive and behavioral function and daily life activities in patients with mild stage dementia.
Methods:
Controlled clinical trial with pre- and post-intervention (12 months) and follow-up (24 months after) evaluations. Participants (67) diagnosed with mild dementia were randomly assigned to intervention group (n = 39) or control group (n = 28). The intervention took place throughout one year and consisted of two weekly 90-minute sessions and one more a year after a monthly follow-up. Instruments were used to evaluate outcomes in cognitive, behavioral, and affective domains.
Results:
The results showed statistically significant differences, with improvement in the cognitive outcomes and the Dementia Index post-intervention (p = 0.01). No progression of the disease was observed at the end of the study.
Conclusion:
The multicomponent intervention tested had positive effects on cognitive and behavioral functions and daily life activities in people with mild stage dementia, delaying progression for at least two years.
Alberca-SerranoR (2007) Manifestaciones Clínicas de la enfermedad de Alzheimer. In Enfermedad de Alzheimer y otras demencias, Alberca R, López-Pousa S, eds. Médica-Panamericana.
6.
CunninghamEL, McGuinnessB, HerronB, PassmoreAP (2015) Dementia. Ulster Med J84, 79–87.
7.
DaroffRB FG, JankovicJ, MazziottaJ (2012) Bradley’s neurology in clinical practice. In Principles of Diagnosis and Management. Elsevier, Saunders, EU.
8.
WoodsRT, BruceE, EdwardsRT, ElvishR, HoareZ, HounsomeB, KeadyJ, Moniz-CookED, OrgetaV, OrrellM, ReesJ, RussellIT (2012) REMCARE: Reminiscence groups for people with dementia and their family caregivers – effectiveness and cost-effectiveness pragmatic multicentre randomised trial. Health Technol Assess16, v-xv, 1–116.
9.
AguirreE, HoareZ, SpectorA, WoodsRT, OrrellM (2014) The effects of a Cognitive Stimulation Therapy [CST] programme for people with dementia on family caregivers’ health. BMC Geriatr14, 31.
10.
LyuJ, ZhangJ, MuH, LiW, ChampM, XiongQ, GaoT, XieL, JinW, YangW, CuiM, GaoM, LiM (2018) The effects of music therapy on cognition, psychiatric symptoms, and activities of daily living in patients with Alzheimer’s disease. J Alzheimers Dis64, 1347–1358.
11.
van der SteenJT, SmalingHJ, van der WoudenJC, BruinsmaMS, ScholtenRJ, VinkAC (2018) Music-based therapeutic interventions for people with dementia. Cochrane Database Syst Rev7, CD003477.
12.
HanserSB, Clements-CortesA, Mercadal-BrotonsM, TomainoCM (2020) Editorial: Music therapy in geriatrics. Front Med (Lausanne)7, 87.
13.
Clements-CortesA, BartelL (2018) Are we doing more than we know? Possible mechanisms of response to music therapy. Front Med (Lausanne)5, 255.
14.
Clements-CortesA, AhonenH, EvansM, FreedmanM, BartelL (2016) Short-term effects of rhythmic sensory stimulation in Alzheimer’s disease: An exploratory pilot study. J Alzheimers Dis52, 651–660.
15.
RayKD, GotellE (2018) The use of music and music therapy in ameliorating depression symptoms and improving well-being in nursing home residents with dementia. Front Med (Lausanne)5, 287.
16.
ChoHK (2018) The effects of music therapy-singing group on quality of life and affect of persons with dementia: A randomized controlled trial. Front Med (Lausanne)5, 279.
17.
Bergado-RosadoJA, Almaguer-MelianW (2000) [Cellular mechanisms of neuroplasticity]. Rev Neurol31, 1074–1095.
AguirreE, SpectorA, OrrellM (2014) Guidelines for adapting cognitive stimulation therapy to other cultures. Clin Interv Aging9, 1003–1007.
21.
KimEY, KimKW (2014) A theoretical framework for cognitive and non-cognitive interventions for older adults: Stimulation versus compensation. Aging Ment Health18, 304–315.
22.
Pena-CasanovaJ, MonllauA, BohmP, AguilarM, SolJM, HernandezG, BlesaR, Grupo NORMACODEM (2005) [Diagnostic value and test-retest reliability of the Blessed Dementia Rating Scale for Alzheimer’s disease: Data from the NORMACODEM project]. Neurologia20, 349–355.
23.
Bahar-FuchsA, ClareL, WoodsB (2013) Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer’s or vascular type: A review. Alzheimers Res Ther5, 35.
24.
SpectorA, ThorgrimsenL, WoodsB, RoyanL, DaviesS, ButterworthM, OrrellM (2003) Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: Randomised controlled trial. Br J Psychiatry183, 248–254.
25.
AguirreE, WoodsRT, SpectorA, OrrellM (2013) Cognitive stimulation for dementia: A systematic review of the evidence of effectiveness from randomised controlled trials. Ageing Res Rev12, 253–262.
26.
OrrellM, SpectorA, ThorgrimsenL, WoodsB (2005) A pilot study examining the effectiveness of maintenance Cognitive Stimulation Therapy (MCST) for people with dementia. Int J Geriatr Psychiatry20, 446–451.
27.
MatsudaH (2007) The role of neuroimaging in mild cognitive impairment. Neuropathology27, 570–577.
28.
SpectorA, OrrellM, WoodsB (2010) Cognitive Stimulation Therapy (CST): Effects on different areas of cognitive function for people with dementia. Int J Geriatr Psychiatry25, 1253–1258.
29.
Vernooij-DassenM, VasseE, ZuidemaS, Cohen-MansfieldJ, MoyleW (2010) Psychosocial interventions for dementia patients in long-term care. Int Psychogeriatr22, 1121–1128.
30.
VasseE, Moniz-CookE, RikkertMO, CantegreilI, CharrasK, DorenlotP, FumeroG, FrancoM, WoodsB, Vernooij-DassenM (2012) The development of quality indicators to improve psychosocial care in dementia. Int Psychogeriatr24, 921–930.
31.
Juarez-CedilloT, Basurto-AcevedoL, Vega-GarciaS, Manuel-ApolinarL, Cruz-TesoroE, Rodriguez-PerezJM, Garcia-HernandezN, Perez-HernandezN, FragosoJM (2014) Prevalence of anemia and its impact on the state of frailty in elderly people living in the community: SADEM study. Ann Hematol93, 2057–2062.
32.
Juarez-CedilloT, Sanchez-ArenasR, Sanchez-GarciaS, Garcia-PenaC, HsiungGY, SepehryAA, BeattieBL, JacovaC (2012) Prevalence of mild cognitive impairment and its subtypes in the Mexican population. Dement Geriatr Cogn Disord34, 271–281.
33.
ReisbergB, FerrisSH, de LeonMJ, CrookT (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry139, 1136–1139.
34.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
35.
Martínez LageJM, Láinez AndrésJM (2000) El Alzheimer: Teoría y práctica. Aula Medica Ediciones.
36.
MonllauA, Pena-CasanovaJ, BlesaR, AguilarM, BohmP, SolJM, HernandezG (2007) [Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer’s disease: Data on NORMACODEM project]. Neurologia22, 493–501.
37.
RosenWG, MohsRC, DavisKL (1984) A new rating scale for Alzheimer’s disease. Am J Psychiatry141, 1356–1364.
38.
RascovskyK, SalmonDP, HansenLA, ThalLJ, GalaskoD (2007) Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer’s disease. Neuropsychology21, 20–30.
39.
Ostrosky-SolisF, ArdilaA, RosselliM (1999) NEUROPSI: A brief neuropsychological test battery in Spanish with norms by age and educational level. J Int Neuropsychol Soc5, 413–433.
40.
KauferDI, CummingsJL, KetchelP, SmithV, MacMillanA, ShelleyT, LopezOL, DeKoskyST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci12, 233–239.
41.
BoadaM, CejudoJC, TarragaL, LopezOL, KauferD (2002) [Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)]. Neurologia17, 317–323.
42.
VazquezC, SanzJ (1997) Fiabilidad y valores normativos de la versión española del Inventario para la Depresión de Beck de 1978. Clin Salud8, 403–422.
43.
MaganI, SanzJ, Garcia-VeraMP (2008) Psychometric properties of a Spanish version of the Beck Anxiety Inventory (BAI) in general population. Span J Psychol11, 626–640.
44.
ZaritSH, ReeverKE, Bach-PetersonJ (1980) Relatives of the impaired elderly: Correlates of feelings of burden. Gerontologist20, 649–655.
45.
GraffMJ, Vernooij-DassenMJ, ThijssenM, DekkerJ, HoefnagelsWH, RikkertMG (2006) Community based occupational therapy for patients with dementia and their care givers: Randomised controlled trial. BMJ333, 1196.
46.
HuntleyJD, GouldRL, LiuK, SmithM, HowardRJ (2015) Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression. BMJ Open5, e005247.
47.
BhomeR, BerryAJ, HuntleyJD, HowardRJ (2018) Interventions for subjective cognitive decline: Systematic review and meta-analysis. BMJ Open8, e021610.
48.
OlazaranJ, MunizR, ReisbergB, Pena-CasanovaJ, del SerT, Cruz-JentoftAJ, SerranoP, NavarroE, Garcia de la RochaML, FrankA, GalianoM, Fernandez-BullidoY, SerraJA, Gonzalez-SalvadorMT, SevillaC (2004) Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology63, 2348–2353.
49.
CoveJ, JacobiN, DonovanH, OrrellM, StottJ, SpectorA (2014) Effectiveness of weekly cognitive stimulation therapy for people with dementia and the additional impact of enhancing cognitive stimulation therapy with a carer training program. Clin Interv Aging9, 2143–2150.
